|
CN105343038A
|
|
Composition and application thereof to drugs for resisting chronic obstructive pulmonary disease (COPD)
|
|
CN105343041A
|
|
Composition and application thereof to drugs for treating or preventing renal fibrosis
|
|
CN105267190A
|
|
Composition and application thereof to drugs for preventing or treating pancreatic fibrosis
|
|
CN105343039A
|
|
Composition and application thereof to drugs for resisting acute gout
|
|
CN105343064A
|
|
Composition and application of composition to preparation of anti-osteoporosis medicines
|
|
CN105343063A
|
|
Composition and application thereof in anti-hypoxia drug
|
|
CN105343065A
|
|
Composition and application of composition to preparation of antiviral medicines
|
|
CN105343074A
|
|
Composition and application thereof in anti-inflammatory drug
|
|
CN105343076A
|
|
Composition and application thereof in acute renal failure resisting drug
|
|
CN105343075A
|
|
Composition and application thereof in leukocyte-increasing drug
|
|
CN105168222A
|
|
Composition and application of composition to anti-rhinitis medicine
|
